Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Neurobiology of Aging|August 22, 2007
Pattern of Tau forms in CSF is altered in progressive supranuclear palsyB Borroni, F Gardoni, L Parnetti, et al.
American Journal of Ophthalmology|March 18, 2019
Three-Year Follow-Up of Phase 1 and 2a rAAV.sFLT-1 Subretinal Gene Therapy Trials for Exudative Age-Related Macular DegenerationElizabeth P Rakoczy, Aaron L Magno, Chooi-May Lai, et al.
Neural Regeneration Research|October 2, 2019
The Schlager mouse as a model of altered retinal phenotypeLakshini Y Herat, Aaron L Magno, Márcio G Kiuchi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2009
Sequestosome 1 mutations in Paget's disease of bone in Australia: prevalence, genotype/phenotype correlation, and a novel non-UBA domain mutation (P364S) associated with increased NF-kappaB signaling without loss of ubiquitin bindingSarah L Rea, John P Walsh, Lynley Ward, et al.
Journal of Cellular Physiology|April 19, 2017
The endoplasmic reticulum-associated protein, OS-9, behaves as a lectin in targeting the immature calcium-sensing receptorBryan K Ward, Sarah L Rea, Aaron L Magno, et al.
The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Functional deletion of the calcium-sensing receptor in a case of neonatal severe hyperparathyroidismBryan K Ward, Aaron L Magno, Elizabeth A Davis, et al.
Experimental Eye Research|April 8, 2014
Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathyJoanna Wisniewska-Kruk, Ingeborg Klaassen, Ilse M C Vogels, et al.
American Journal of Ophthalmology|March 2, 2017
Gene Therapy in Neovascular Age-related Macular Degeneration: Three-Year Follow-up of a Phase 1 Randomized Dose Escalation TrialIan J Constable, Chooi-May Lai, Aaron L Magno, et al.
JACC. Basic to Translational Science|March 7, 2020
SGLT2 Inhibitor-Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal ProtectionLakshini Y Herat, Aaron L Magno, Caroline Rudnicka, et al.
Lancet (London, England)|October 4, 2015
Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trialElizabeth P Rakoczy, Chooi-May Lai, Aaron L Magno, et al.
Pageof 5